B Background
• Surgical resection (R) and stereotactic body radiotherapy (SBRT) in early stage lung cancer represent potentially curative treatments.
• Historically, controlling for age, comorbidities and other important factors, fewer black than white patients undergo curative surgery resulting in higher mortality.
• Accountability for Cancer Care through Undoing Racism and Equity (ACCURE) is an NIH sponsored multi-institutional trial designed to test a multimodal intervention to reduce racial disparities and increase treatment completion for all early stage breast and lung cancer.
• The ACCURE multi-modal systems change consists of:
• Real time registry with automated alerts for missed appointments and unmet milestones in expected care
• Race-specific data feedback on treatment adherence
• ACCURE nurse navigator trained in race-specific barriers with special training regarding trust, culturally appropriate communication, and Kleinman's explanatory model
• Quarterly Health Equity Education Training (HEET) sessions for staff.
M Materials/Methods 
R Results
• Overall treatment improved significantly in the enrolled ACCURE intervention group and control group compared to baseline.
• The statistically significant treatment disparity also resolved.
• The surgical approach was the vehicle of improvement within the ACCURE intervention cohort.
• SBRT explained improved care and resolution of disparities in the overall cancer center populations.
• In the randomized controlled trial, comparing ACCURE navigator vs. usual care, there was elimination of disparity with high rates of treatment completion in both arms without statistically significant difference.
